The U.S. Food and Drug Administration issued a draft guidance on Wednesday to help drug developers validate alternative methods that can be used in place of animal studies during early stages of drug ...
Drug developers will be able to use alternatives to animal testing and possibly get new products to market faster under draft guidance issued Wednesday by the FDA. In a press release, officials said ...
From navigation systems to hardware, here are nine spine technologies earning FDA certifications and clearances since Jan. 19. 1. Cresco Spine earned FDA 510(k) clearance for its spring distraction ...
Image courtesy of Revolve Surgical] Revolve Surgical announced today that it received FDA 510(k) clearance for its surgical robot platform. The Canada-based company develops what it describes as a ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
A curated partner ecosystem uniting methodology, technology, and managed services to move life sciences from compliance ...
Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...
FDA Rare Diseases FILE - President Donald Trump listens as Dr. Marty Makary, commissioner of the Food and Drug Administration, speaks in the Roosevelt Room of the White House, Monday, Sept. 22, 2025, ...
Read full article: WEEKEND FORECAST: When & where to expect storms At least one person died Saturday after a motorcycle and a motor vehicle collided in Uvalde. Read full article: DPS: Motorcycle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results